Inshad Ali Khan
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 10
- Pharmacology top 0.5%
- Piperaceae Chemical and Biological Studies 9
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology 24
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 10
- Pharmacology top 2%
- Piperaceae Chemical and Biological Studies 9
-
- Synthesis and biological activity 16
- Synthesis and Biological Evaluation 13
-
- Phenothiazines and Benzothiazines Synthesis and Activities 16
- Cancer therapeutics and mechanisms 14
- Co-authors
- Nitin Pal KaliaAmit NargotraAshwani KumarGhulam N. QaziVikrant Singh RajputRukmankesh MehraFurqan AliM. Kumar
- Journals
- European Journal of Medicinal Chemistry (12 papers)Tuberculosis (4 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)
- Partner nations
- IndiaChinaUnited States
In The Last Decade
Inshad Ali Khan
97 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 136
- Molecular Medicine 541
- Pharmacology 457
- Infectious Diseases 698
- Toxicology 116
- Pharmacology 519
Countries citing papers authored by Inshad Ali Khan
This map shows the geographic impact of Inshad Ali Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inshad Ali Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inshad Ali Khan more than expected).
Fields of papers citing papers by Inshad Ali Khan
This network shows the impact of papers produced by Inshad Ali Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inshad Ali Khan. The network helps show where Inshad Ali Khan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Inshad Ali Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 34 | |
| 2 | 2023 | 3 | |
| 3 | 2021 | 8 | |
| 4 | 2020 | 12 | |
| 5 | 2020 | 3 | |
| 6 | 2018 | 20 | |
| 7 | 2017 | 34 | |
| 8 | 2016 | 17 | |
| 9 | 2015 | 21 | |
| 10 | 2015 | 21 | |
| 11 | 2013 | 38 | |
| 12 | 2013 | 24 | |
| 13 | 2012 | 40 | |
| 14 | 2012 | 61 | |
| 15 | 2011 | 22 | |
| 16 | 2010 | 139 | |
| 17 | 2010 | 21 | |
| 18 | 2010 | 165 | |
| 19 | Biologically active hydroxymoyl chlorides as antifungal agents | 2008 | 2 |
| 20 | Potential biologically active agents. X. Synthesis of 3-arylimino-2-indolinones, and their 1-methyl- and 1-morpholino/piperidinomethyl derivatives as excystment and cysticidal agents against Schizopyrenus russelli. | 1977 | 10 |
About Inshad Ali Khan
Inshad Ali Khan is a scholar working on Toxicology, Molecular Medicine and Pharmacology, having authored 97 papers that have together received 3.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (24 papers), Synthesis and biological activity (16 papers), Phenothiazines and Benzothiazines Synthesis and Activities (16 papers), Cancer therapeutics and mechanisms (14 papers), Synthesis and Biological Evaluation (13 papers), Bioactive Compounds and Antitumor Agents (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Piperaceae Chemical and Biological Studies (9 papers). The work is most often cited by research in Molecular Medicine (541 citations), Pharmacology (457 citations) and Infectious Diseases (698 citations). Inshad Ali Khan has collaborated with scholars based in India, China and United States. Frequent co-authors include Nitin Pal Kalia, Amit Nargotra, Ashwani Kumar, Ghulam N. Qazi, Vikrant Singh Rajput, Rukmankesh Mehra, Furqan Ali, M. Kumar, Ram A. Vishwakarma and Samsher Singh. Their work appears in journals such as European Journal of Medicinal Chemistry, Tuberculosis, Bioorganic & Medicinal Chemistry Letters, Journal of Antimicrobial Chemotherapy and Applied Microbiology and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.